| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |